Guidelines and Standards

The UK standards for Paediatric Endocrinology are below, followed by other guidelines and standards sorted into endocrine and diabetes.

Each patient should be considered as an individual in the context of their condition and other medication and therefore the readers' discretion is required in the application of their use of these guidelines and standards. Every effort has been made to ensure the factual accuracy of the contents but no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines and standards.

If you have a query or comment, or would like to raise a concern about any document on this page, please contact the BSPED Office who will ensure your message is passed to the BSPED Clinical Guidelines Officer and Clinical Committee.

Included on this page are:

• BSPED Guidelines and Standards (guidelines produced for the BSPED): Commissioned and developed by BSPED and reflect the Society's views on best practice for the majority of patients with that condition. 
• BSPED Endorsed Guidelines and Standards: Produced by accredited national bodies (e.g. NICE, RCPCH, ACDC) of which BSPED are stakeholders. BSPED may have been involved in the development, but are not the original authors.
• Local Guidelines: The BSPED has not been involved in the development of these guidelines and takes no responsibility for the content. Please note local guidelines may vary between trusts.

For BSPED endorsement of a guideline or standard please review the BSPED Clinical Guideline/Standard Endorsement Process. Authors of guidelines/standards are required to sign the BSPED Declaration of Interest form (definitions of conflicting interests are listed on the form).

UK standards for Paediatric Endocrinology

The UK standards for Paediatric Endocrinology were initially published in 2019 and have been updated in 2024 by the BSPED. They are endorsed by the Royal College of Paediatrics and Child Health. The standards apply to all children and young people aged 0-18 years with an endocrine condition. The aims of the standards are to reduce variability in care and to ensure that equitable services providing high quality, safe and effective care are available to all children and families across the UK. The standards are intended for healthcare professionals and for service commissioners to plan, deliver and quality assure paediatric endocrine services. Review date: January 2029.

Chaperone documentation for clinical notes (provided by Birmingham Children's Hospital):